Remember Me
Log in
Forgot your password?
Register
About
ECCO
ECCO General Assembly
ECCO Governing Board
The Council of National Representatives
ECCO Operational Board
SciCom
EduCom
S-ECCO
ClinCom
GuiCom
P-ECCO
EpiCom
N-ECCO
Y-ECCO
H-ECCO
D-ECCO
Committee Podcasts
Affiliate ECCO Societies & ECCO Partners
ECCO Office
ECCO Disclosures
ECCO & IBD
ECCO Elections
Visitors Area
Members Area
Congresses & Events
Future Congresses
15th Congress of ECCO, Vienna 2020
14th Congress of ECCO, Copenhagen 2019
Past Congresses
13th Congress of ECCO, Vienna 2018
12th Congress of ECCO, Barcelona 2017
11th Congress of ECCO, Amsterdam 2016
10th Congress of ECCO, Barcelona 2015
9th Congress of ECCO, Copenhagen 2014
8th Congress of ECCO, Vienna 2013
7th Congress of ECCO, Barcelona 2012
6th Congress of ECCO, Dublin 2011
ECCO Educational Workshops
Event Calendar
Quality Assurance/Endorsement
Membership
Individual Membership
Register/ Renew
Country Members
Corporate Membership
Education
Educational Workshops
e-CCO Learning
IBD Nurse Education Programme
ClinCom Workshop
D-ECCO Workshop
EpiCom Workshop
ECCO-AOCC Forum
ECCO: EduCational COurse for Industry
Guideline Methodology and GRADE Workshop
H-ECCO IBD Masterclass
IBD Intensive Advanced Course
Imaging Workshops
N-ECCO Network Meeting
N-ECCO School
N-ECCO Research Forum
P-ECCO Educational Course
School for Clinical Trialists
SciCom Workshop
S-ECCO IBD Masterclass
Y-ECCO Basic Science Workshop
Y-ECCO Career Workshop
Science
UR-CARE
Fellowships and Grants
Scientific Workshops
Research Projects
ECCO CONFER Cases
Job postings
Publications
ECCO Topical Review
Published ECCO Topical Reviews
ECCO Guidelines
Published ECCO Guidelines
ECCO e-Guide
Surveys
JCC
JCC local editions
10 Year JCC Anniversary
ECCO News
Letters from the President
Committee News
Congress News
Literature Reviews
UR-CARE
EU Projects
ECCO Country Member Profiles
ECCO-EFCCA Patient Guidelines
CD Patient Guidelines
UC Patient Guidelines
Congress Abstracts
Abstracts 2019
Abstracts 2018
Abstracts 2017
Abstracts 2016
Abstracts 2015
Abstracts 2014
Abstracts 2013
Abstracts 2012
Abstracts 2011
eNewsletter
Other publications
Public Affairs
Press & Awareness
EU Research Projects
FP7 Sadel Project
Horizon 2020 - BIOCYCLE Project
Publications
Congress Abstracts
Abstracts 2013
Poster presentations: Basic Science (2013)
Search
in the Abstract Database
Search
Abstracts 2013
* = Presenting author
Poster presentations: Basic Science (2013)
P001. Interleukin-21 exerts pathogenic and host-protective effects in experimental models of colitis
P002. Intestinal homeostasis is critically regulated by the transcription factor T-bet
P003. Selective inhibition of eIF2alpha dephosphorylation prevents colitis and shows therapeutic potential in a new model of ulcerative colitis
P004. Smooth muscle cells participate in Crohn's disease intestinal fibrosis
P005. T cell KV1.3 channel expression level in biopsies from patients with active ulcerative colitis is higher in patients treated with immunosuppressants and 5-ASA versus 5-ASA alone
P006. Tauro-ursodeoxycholic acid ameliorates experimental colitis in mice
P007. The aetiology, immune activation and homing profile of dendritic cells in fistulating perianal Crohn's disease
P008. The amount of keratins in colonic epithelial cells matter for stress protection
P009. The changes of the NO-ergic system, arginase and oxidative processes in the muscular layer of the colon under the conditions of stress and experimental colitis
P010. The effect of interleukin-1 receptor antagonism in the management of intestinal inflammation; an in vitro and in vivo study
P011. The effect of melatonin treatment on DSS induced colitis and probable mechanism by microarray
P012. The effects of faecal microbiota transplantation on the innate immune system and epithelial tight junction expression in chronic refractory pouchitis
P013. The fall of estrogen receptors expression in long-lasting ulcerative-associated carcinoma
P014. The inflammasome induces macrophage-mediated disruption of the epithelial barrier
P015. The influence of COX-1/COX-2 inhibitors on the Na/Li-countertransport and Na,K,2Cl-cotransport in erythrocytes of rats with experimental colitis
P016. The lack of tumour necrosis factor alpha downregulation on basic fibroblast growth factor/syndecan 1 link may be a relevant molecular pathway in Crohn's disease fibrotic stenosis
P017. The miRNA-29 family regulates NOD2-dependent IL-23 expression in human DCs and limits intestinal pathology in a mouse model of mucosal inflammation
P018. The role of human colonic ion transporters in diarrhea-associated diseases
P019. The role of human neutrophil elastase and its inhibitor elafin in ulcerative colitis
P020. The Th17 cell population in the peripheral blood in patients with Crohn's disease
P021. The urokinase plasminogen activator receptor (uPAR) regulates intestinal macrophage phagocytosis and polarization in experimental colitis
P022. Therapeutic effect of adipose tissue-derived stem cell in Interleukin-10 knockout mice
P023. Therapy with FREMS (Frequency Rhythmic Electrical Modulation System)
P024. Ulcerative colitis versus Crohn's disease: differences observed in the IMPACT survey
P025. Vedolizumab does not affect the suppressive activity of gut-homing T regulatory cells
P026. Vitamin D enhances macrophage function and improves killing of Crohn's associated E. coli
P027. Vitamin D potentiates the immunosuppressive effect of anti-TNF induced regulatory macrophages
P028. Inflammatory cytokines specifically regulate endoplasmic reticulum stress in colitis
P029. Inflammasome activation P2X7-dependent in Crohn's disease
P030. High fat diet aggravates Crohn's disease-like ileitis independently of obesity via alterations of epithelial barrier homeostasis
P031. Simultaneously restoration of Foxp3 (+) regulatory T cells subsets, type 1-like regulatory T cells and B cells correlates with clinical response to infliximab therapy for IBD
P032. Serum hepcidin in inflammatory bowel diseases
P033. Serum hepcidin expression varies with disease activity in Crohn's disease
P034. Serum concentration of estrogen is associated with inflammatory bowel disease activity
P035. Salicin ameliorates the inflammation and prevents the loss of gut flora in DSS induced mice model of colitis
P036. SPARC affects colorectal tumourigenesis
P037. Role of ghrelin and melatonin in pathogenesis of clinical and experimental inflammatory bowel disease
P038. Role of 5-HT3 receptors in the anti-inflammatory effects of alosetron in a rat model of colitis
P039. Reprogramming of intestinal epithelial cells by interleukin-22
P040. Protein tyrosine phosphate non receptor type 22 regulates muramyl-dipeptide induced effects in human monocytes
P041. Piroxicam-accelerated colitis in interleukin-10 knock out mice – a “new” model of human inflammatory bowel disease
P042. Patients' preferences when selecting biologics for inflammatory bowel disease
P043. PRKCDBP, a new transcriptional target of TNF-alpha signaling pathway in ulcerative colitis
P044. Novel image using hydrogen sulfide multiphoton probe in the mucosal tissue of ulcerative colitis patients
P045. Mycobacterium avium subsp. paratuberculosis survival in macrophages from inflammatory bowel disease patients
P046. Mucosal immune activation in diarrhea-predominant irritable bowel syndrome: comparison with health controls and ulcerative colitis
P047. Metformin inhibits NF-κB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice
P048. Metallothionein, an emerging danger signal during experimental colitis
P049. Longitudinal assessment of epithelial and immune cell changes following ileostomy closure in patients with ulcerative colitis
P051. Inhibition of lymphangiogenesis via VEGFR-3 as a novel therapy for IBD-related colorectal cancer
P052. Inhibition of Th17 cells but not of Tregs affects extracellular matrix protein deposition in chronic DSS colitis
P053. Influence of NADPH oxidase on inflammatory response in the primary intestinal epithelial cells from patients with ulcerative colitis
P054. In experimental model of colitis the therapeutic efficacy of mesenchymal stem cells is not gut-homing dependent but is mediated at distance by secretion of TNF-alfa stimulated gene/protein 6
P055. HDAC dependent regulation of the IL-6/STAT3 pathway during T helper cell activation
P056. GED-0507–34 Levo, a novel modulator of PPARgamma as new therapeutic strategy in the treatment of intestinal fibrosis
P057. Micro-RNA expression profiling identifies miR-29b as a relevant pro-fibrogenic factor in Crohn's disease intestinal strictures
P058. In vivo formation of 8-iso-prostaglandin F2 α and platelet activation in inflammatory bowel disease
P059. Immunohistochemical expression of angiopoietin 1 (Ang1), CD34 and D2.40 in colon of patients with inflammatory bowel disease (IBD) and its association with endoscopic activity
P060. Immune unresponsiveness of human intestinal dendritic cells in ulcerative colitis is reversed by a novel bacterial peptide STp
P061. Ileum versus colon: separate roles for gut dendritic cells in mucosal immune homeostasis and implications for ulcerative colitis
P062. Ileal gene expression profiling of Crohn's disease underlines the importance of the inflammatory load during the disease course
P063. IL-21 and IL-21 receptor expression in the intestine from patients with Crohn's disease
P064. IL-21 neutralization in experimental colitis: regulation of cytokines, chemokines and colonic transcripts
P065. Humoral immune response to intestinal microbiota in inflammatory bowel diseases
P066. Human intestinal Vδ2+ T-cells promote mucosal inflammation in Crohn's disease and are selectively ablated by azathioprine therapy
P067. Human and rodent ex vivo model for intestinal fibrosis in inflammatory bowel disease (IBD)
P068. High expression level of the T cell potassium channel, KV1.3, is a novel diagnostic marker of inflammatory activity in patients with ulcerative colitis
P069. Glycine and glutamine down-regulate IL-6-induced claudin-2 expression in human colonic epithelial cell monolayer
P070. Genetic polymorphisms of interleukin 15 (IL-15) in patients with ulcerative colitis
P071. Gelenterum ameliorates murine colitis while modulating gut microbiota and intestinal mucus layer
P072. Ezrin, LAMC2 and ITG α 6 as possible biomarkers of ulcerative colitis-associated colonic dysplasia
P073. Ex vivo activation of triggering receptor expressed on myeloid cells 1 enhances the production of pro-inflammatory cytokines by inflammatory bowel disease mucosa
P074. Extracellular matrix protein expression in chronic repeated DSS colitis reflects transmural remodeling in human Crohn's disease
P075. Evolutive profile of biomarkers in postoperative Crohn's disease patients: identification of recurrence risk predictors
P076. Epithelial apoptotic loss is enhanced even in tissue from uninflamed mucosa in patients with Crohn's disease
P077. Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and epithelial repair
P078. Efficacy of human anti-macrophage migration inhibitory factor antibodies in mouse models of inflammatory bowel disease
P079. Effects of a mixture of amino acids on colonic mucosa healing after experimental colitis
P080. Effect of insulin like growth factor-1 on experimental colitis
P081. Effect of condroitin sulphate on pro-inflammatory mediators and disease activity in patients with inflammatory bowel disease (IBD)
P082. Altered oligosaccharide structures reduce colitis induction in mice defective in glycosyltransferases
P083. ADAMDEC1: a novel molecule linked to Crohn's disease, is associated with an increased susceptibility to Citrobacter rodentium colitis in the knock out mouse
P084. Effect of infliximab on monocyte subtypes in blood of patients with chronic inflammatory bowel disease
P085. Effect of phytoestrogenic dietary supplementation on the progression of chronic intestinal inflammation to cancer in an animal model
P086. Donor dependent efficacy of human mesenchymal stromal cell treatment in experimental colitis
P087. Differentially expressed microRNAs regulate expression of genes with clinical interest in inflamed colon of patients with ulcerative colitis
P088. Differential expression of prolyl hydroxylases 1 and 3 between IBD and non-IBD patients
P089. Differential effects of sulphasalazine, azathioprine and prednisolone on the NF-kB, heparanase, HSP70 and HPRT gene expression in the TNBS-induced intestinal inflammation
P090. Differential effects of sulphasalazine, azathioprine and prednisolone on the MAP-kinases gene expression in the TNBS-induced intestinal inflammation
P091. Development of a patient-reported outcome measure for Crohn's disease
P092. Detection of apoptosis in intestinal mucosa and mesenteric fat tissue of Crohn's disease
P093. Dendritic cell characteristics in pouchitis
P094. Defective CSF2RB signaling in Crohn's disease patients bearing the NCF4 risk allele
P095. Dipotassium glycyrrhizate ameliorates DSS-induced colitis in mice by HMGB1 inhibition
P096. Circulating components of the alternative renin–angiotensin system are upregulated in patients with inflammatory bowel disease
P097. The efficacy of benzoxazole derivatives (B-98) as 5-lipooxygenase inhibitor and the change of T cell profiles in acute murine colitis model
P098. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease
P099. Anti-TNF-alpha treatment improves carbohydrate metabolism in patients with inflammatory bowel disease
P100. A novel therapeutic target linking diet to disease pathogenesis in ulcerative colitis: the aryl hydrocarbon receptor
P101. Analysis of the protease MT1-MMP and its substrates as biomarkers in IBD
P102. Altered epithelial tight junction expression and elevated IL 6 levels in pouchitis
P103. Adding fuel to the fire – neutrophils as antigen presenting cells in Crohn's disease
P104. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis in Mexican population
P105. Active inflammation of the appendix in ulcerative colitis
P106. Active macrophage migration inhibitory factor (MIF) is a previously unrecognized isoform of MIF and a potential new biomarker for inflammatory bowel diseases
P107. Action of leukocytapheresis is associated with calcitonin gene-related peptide induction in colitis models
P108. FAM5C, a possible causal molecule in ulcerative colitis revealed through a transcriptomic analysis of the bowel mucosa